Total Payments
$722.10
2024 Payments
$169.48
Companies
16
Transactions
49
Medicare Patients
722
Medicare Billing
$37,538
Payment Breakdown by Category
Food & Beverage$622.11 (86.2%)
Education$99.99 (13.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $622.11 | 48 | 86.2% |
| Education | $99.99 | 1 | 13.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $213.19 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $116.79 | 5 | $0 (2022) |
| Novo Nordisk Inc | $62.00 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.75 | 3 | $0 (2022) |
| Lilly USA, LLC | $35.95 | 2 | $0 (2024) |
| ITI, Inc. | $33.40 | 2 | $0 (2023) |
| Amgen Inc. | $30.23 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $30.20 | 2 | $0 (2023) |
| Esperion Therapeutics, Inc. | $28.90 | 2 | $0 (2024) |
| Lundbeck LLC | $26.59 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $169.48 | 10 | Novo Nordisk Inc ($31.59) |
| 2023 | $71.16 | 5 | Merck Sharp & Dohme LLC ($16.34) |
| 2022 | $241.70 | 13 | Astellas Pharma US Inc ($116.79) |
| 2021 | $239.76 | 21 | AbbVie Inc. ($185.89) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Rare Disease | ||||||
| 08/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Bone Health | ||||||
| 06/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.82 | General |
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Obesity | ||||||
| 04/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: CNS | ||||||
| 04/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Obesity | ||||||
| 01/22/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Obesity | ||||||
| 01/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Diabetes | ||||||
| 09/19/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Bone Health | ||||||
| 08/17/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/25/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Obesity | ||||||
| 08/24/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 08/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: DIABETES | ||||||
| 06/21/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Urology | ||||||
| 06/08/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Urology | ||||||
| 03/22/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Urology | ||||||
| 03/22/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 126 | 188 | $29,699 | $7,889 |
| 2022 | 5 | 170 | 247 | $36,350 | $10,392 |
| 2021 | 11 | 235 | 301 | $32,972 | $9,462 |
| 2020 | 6 | 191 | 268 | $37,889 | $9,795 |
Total Patients
722
Total Services
1,004
Medicare Billing
$37,538
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 81 | $15,795 | $4,044 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 47 | $12,826 | $3,154 | 24.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 35 | 49 | $539.00 | $411.60 | 76.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $539.00 | $278.96 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 91 | $17,745 | $4,495 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 60 | $15,900 | $4,187 | 26.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 16 | 16 | $1,217 | $1,124 | 92.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $784.00 | $395.84 | 50.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 44 | 64 | $704.00 | $189.72 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 83 | $15,905 | $3,978 | 25.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 47 | $12,455 | $3,231 | 25.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 13 | 13 | $988.65 | $863.59 | 87.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 16 | 16 | $784.00 | $449.60 | 57.3% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 12 | 12 | $588.00 | $284.28 | 48.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 17 | 17 | $833.00 | $267.42 | 32.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $637.00 | $186.81 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 41 | 55 | $605.00 | $165.00 | 27.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 11 | 16 | $176.00 | $36.00 | 20.5% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 14 | 15 | $0.15 | $0.15 | 100.0% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 11 | 14 | $0.14 | $0.14 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 91 | $16,471 | $3,664 | 22.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 56 | $14,840 | $3,234 | 21.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 23 | 23 | $1,748 | $1,403 | 80.2% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 15 | 18 | $3,038 | $923.58 | 30.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 24 | 24 | $1,176 | $402.48 | 34.2% |
About Sarah Baker, FNP
Sarah Baker, FNP is a Nurse Practitioner healthcare provider based in Fargo, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1780832634.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Baker, FNP has received a total of $722.10 in payments from pharmaceutical and medical device companies, with $169.48 received in 2024. These payments were reported across 49 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($622.11).
As a Medicare-enrolled provider, Baker has provided services to 722 Medicare beneficiaries, totaling 1,004 services with total Medicare billing of $37,538. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Fargo, ND
- Active Since 09/04/2008
- Last Updated 05/11/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1780832634
Products in Payments
- UBRELVY (Drug) $124.73
- VRAYLAR (Drug) $53.01
- JARDIANCE (Drug) $45.75
- CAPLYTA (Drug) $33.40
- Wegovy (Drug) $31.59
- EVENITY (Biological) $30.23
- BELSOMRA (Drug) $30.20
- NEXLETOL (Drug) $28.90
- REXULTI (Drug) $26.59
- LILETTA (Drug) $23.98
- ZEPBOUND (Drug) $23.02
- Saxenda (Drug) $19.09
- STRENSIQ (Biological) $17.49
- Myrbetriq (Drug) $16.80
- ZENPEP (Drug) $14.32
- Tymlos (Biological) $14.20
- NUCALA (Biological) $13.93
- ARISTADA (Drug) $13.34
- MOUNJARO (Drug) $12.93
- Ozempic (Drug) $11.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Fargo
Emily Greenstein, Aprn, Agnp-C, APRN, AGNP-C
Nurse Practitioner — Payments: $240,738
Nurse Practitioner $240,738
Sarah Matcha, Rn, Cnp, RN, CNP
Nurse Practitioner — Payments: $16,429
Nurse Practitioner $16,429
Mrs. Andrea Hanson
Nurse Practitioner — Payments: $2,890
Nurse Practitioner $2,890
Richard Schue, Np, NP
Nurse Practitioner — Payments: $1,861
Nurse Practitioner $1,861
Aaron Lindstrom, Np, NP
Nurse Practitioner — Payments: $1,850
Nurse Practitioner $1,850
Haley Fisher, Dnp, DNP
Nurse Practitioner — Payments: $1,427
Nurse Practitioner $1,427